Hong Kong-based molecular diagnostic company DiagCor is now offering Natera's Panorama test for noninvasive detection of fetal aneuploidies. The test screens for trisomy 21, trisomy 18, trisomy 13, monosomy X, triploidy, and sex chromosome aneuploidies.
The Genomics and Pathology Services Laboratory at Washington University in St. Louis has launched CardioGene Set, a 69-gene next-generation sequencing-based test that screens for cardiomyopathies and arrhythmias.